TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan · Delayed Price · Currency is TWD 11.35
+0.05 (0.44%)
Mar 24, 2026, 1:30 PM CST
TPEX:4157 Market Cap
TPEX:4157 has a market cap or net worth of 8.04 billion as of March 23, 2026. Its market cap has decreased by -6.62% in one year.
Market Cap
8.04B
Enterprise Value
7.07B
Revenue
259.47M
Ranking
n/a
PE Ratio
188.33
Stock Price
11.35
Market Cap Chart
Since September 5, 2013, TPEX:4157's market cap has decreased from 42.07B to 8.04B, a decrease of -80.88%. That is a compound annual growth rate of -12.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 8.04B | -15.67% |
| Dec 31, 2025 | 9.54B | 16.05% |
| Dec 31, 2024 | 8.22B | -24.67% |
| Dec 29, 2023 | 10.91B | -5.16% |
| Dec 30, 2022 | 11.51B | 4.22% |
| Dec 30, 2021 | 11.04B | -32.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tanvex BioPharma | 11.28B |
| TCM Biotech International | 11.01B |
| Gongwin Biopharm Holdings | 8.80B |
| PharmaEngine | 8.36B |
| Adimmune | 7.65B |
| Acepodia | 7.01B |
| Mycenax Biotech | 6.56B |
| Savior Lifetec | 6.40B |